Samsung Biologics.
Korean company
- Reports this week
- 1
- Active events
- 1
- Connections
- 18
What's happening
Active this week
Earlier this month
One to three months ago
-
PolyPeptide Group AG is facing a tender offer from unknown parties, involving Samsung Biologics.Well supported9 reports1 development inside
-
Samsung Biologics utilized a Swiss subsidiary to make an offer.Some support1 report
-
Samsung Biologics acquired PolyPeptide Group and is expanding its second bio campus in Songdo.Some support1 report
Gone quiet
No new reports in 90+ days-
Samsung Biologics, a South Korean company, is aligning its corporate reporting practices with voluntary European Sustainability Standards.Some support2 reports
-
Micron Technology, Samsung Electronics, and Samsung Biologics are facing market volatility due to earnings and are part of the KOSPI market recovery.Some support1 report2 developments inside
-
Samsung Biologics is confirmed as a part of the larger Samsung Group.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Samsung Biologics this week
News at the entities that move Samsung Biologics most-
Samsung Group StructuralSam Altman and OpenAI engaged with Samsung executives and presidents regarding technology collaboration.Moves Samsung Biologics
-
Switzerland StructuralCommentary highlights the political contrast between Israel and Gaza, noting Hamas's control since 2007, alongside a trip from Switzerland.Moves Samsung Biologics
-
Samsung Electronics StructuralSamsung Electronics produces the rugged Galaxy XCover7 Pro.Moves Samsung Biologics
-
Europe StructuralConnaughton covered issues in Africa and Europe while addressing local concerns on Long Island from Columbia University.Moves Samsung Biologics
-
India OperationalA Khalistan referendum was held in Edmonton, Canada, while India questions conditions similar to France.Moves Samsung Biologics
-
Incheon Shared contextThe World Education Forum held an event in Incheon, South Korea, addressing global crises and testing global citizenship principles.Moves Samsung Biologics
Connections
The 12 strongest of 18, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
PolyPeptide Group Transactional
Samsung Biologics is pursuing an all-cash offer to acquire PolyPeptide Group.
-
Switzerland Structural
Samsung Biologics utilizes a Swiss subsidiary to facilitate its market offering.
-
Samsung Electronics Structural
Samsung Biologics is affiliated with Samsung Electronics through the broader Samsung Group corporate structure.
-
Samsung Electro-Mechanics Operational
The two companies are actively competing while simultaneously undergoing a corporate restructuring that sees them leave the larger group body.
-
Samsung Group Structural
Samsung Biologics is formally established as an affiliate of the Samsung Group.
-
Europe Structural
Samsung Biologics is aligning its corporate reporting practices to comply with European sustainability standards.
-
LG Energy Solution Mentioned together
Both LG Energy Solution and Samsung Biologics are identified as major listed companies in South Korea.
-
India Operational
The relationship is characterized by Samsung Biologics' global expansion into India's key markets.
Show all 12 connections
-
Songdo Shared context
Samsung Biologics is expanding its bio campus operations within the Songdo location.
-
Incheon Shared context
Samsung Biologics is operating and expanding facilities within the geographical context of Incheon.
-
Changxin Memory Technologies Shared context
Both entities are mentioned in the context of intensifying global industry competition.
-
Seoul Shared context
Samsung Biologics operates within the context of Seoul, where its earnings performance is reported.
History
Events by the month they beganOctober 2026
2 eventsAugust 2026
2 eventsJuly 2026
1 eventShow 1 earlier month
June 2026
3 events- Samsung Biologics, a South Korean company, is aligning its corporate reporting practices with voluntary European Sustainability Standards.
- Micron Technology, Samsung Electronics, and Samsung Biologics are facing market volatility due to earnings and are part of the KOSPI market recovery.
- Samsung Biologics is confirmed as a part of the larger Samsung Group.